Avita Medical | Betriebsergebnis



Operating Profit Veränderung Datum
Adcock Ingram Holdings ZAR 487.33M 8.25M 2024-12
Celltrion KRW 147.6B 59.32B 2025-03
Clinuvel Pharmaceuticals AUD 39.05M 21.49M 2024-06
Cochlear AUD 274.6M 54.5M 2024-12
CSL USD 1.98B 778M 2024-12
Cspc Pharmaceutical CNY 1.79B 940.51M 2025-03
Dianthus Therapeutics USD -31916000 2.02M 2024-12
Divis Laboratories Ltd 7.79B 1.35B 2025-03
Kangmei Pharma CNY 13.09M 2.91M 2025-03
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 123.07M 85.91M 2024-12
Malin Corporation EUR -1100000 400K 2024-12
Mayne Pharma AUD -3300000 15.67M 2024-06
Medical Developments International AUD 182K 20.42M 2024-12
Nanosonics AUD 8.7M 6.12M 2024-12
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Organigram Holdings CAD -11305000 11.59M 2024-12
Pacific Edge NZD -15314000 7.45M 2024-09
Paradigm Biopharmaceuticals AUD -5930700 3.79M 2024-12
Pharma Mar EUR -3085000 7.98M 2025-03
Polynovo AUD 513K 902K 2024-06
PYC Therapeutics AUD -25891160 14.18M 2024-12
Qiagen NV USD 125.16M 19M 2025-03
Ramsay Health Care AUD 200M 285.4M 2024-12
ResMed USD 417.24M 29.93M 2024-12
Sartorius EUR 137.4M 2.6M 2025-03
Sino Biopharmaceutical CNY 1.33B 2.53B 2024-12
Telix Pharmaceuticals AUD 41.99M 19.97M 2024-06
Tilray USD -42218000 5.65M 2024-11
Zz Pientze Pharmaceu 1.19B 803.71M 2025-03



Avita Medical Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2025.